Show simple item record

dc.contributor.authorFrizziero, Melissa
dc.contributor.authorKilgour, Elaine
dc.contributor.authorSimpson, Kathryn L
dc.contributor.authorRothwell, Dominic G
dc.contributor.authorFrese, Kristopher K
dc.contributor.authorGalvin, Melanie
dc.contributor.authorChen, Yitao
dc.contributor.authorKerr, Alastair
dc.contributor.authorHumphrey, Sam
dc.contributor.authorHossain, Mukarram
dc.contributor.authorValle, Juan W
dc.contributor.authorMcNamara, Mairead G
dc.contributor.authorDive, Caroline
dc.date.accessioned2023-05-17T09:50:54Z
dc.date.available2023-05-17T09:50:54Z
dc.date.issued2022en
dc.identifier.citationFrizziero M, Kilgour E, Simpson KL, Rothwel D, Frese K, Galvin M, et al. The first circulating tumor cell-derived explant (CDX) model of a Merkel cell carcinoma. Cancer Research. 2022 Jun;82(12). PubMed PMID: WOS:000892509508359.en
dc.identifier.doi10.1158/1538-7445.AM2022-3098en
dc.identifier.urihttp://hdl.handle.net/10541/626275
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1158/1538-7445.AM2022-3098en
dc.titleThe first circulating tumor cell-derived explant (CDX) model of a Merkel cell carcinomaen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentCancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Manchester,en
dc.identifier.journalCancer Researchen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record